Last edited: October 30, 2026
A genetic mutation in a tumor does not automatically indicate an inherited predisposition to cancer. For treatment and family counseling, it is important to clarify which cells were tested and what question the test was intended to answer. Even a variant of uncertain significance is neither definitive proof of risk nor a guarantee that there is no risk.[1]
As Herbert Eder, I would like to make this medical terminology understandable. The focus here is on inheritance, test results, and counseling. For frequency therapy, the distinction is particularly clear: A technical or symbolic association with a gene does not replace either its laboratory confirmation or proof that a disease-relevant variant can be specifically modified.
How do cancer cells develop from altered body cells?
Not every change leads to cancer. Often, multiple changes accumulate over a long period of time until a cell’s behavior is significantly altered. Which combination is significant varies from disease to disease and from person to person. Therefore, it is not possible to derive a general minimum number of six mutations that would allow a finding to be reliably classified as harmless or dangerous. [1]
Even normal-appearing tissue can contain cells with mutations in genes associated with cancer. A study of normal esophageal mucosa from nine people showed that such cell clusters can become more common with age. The study examined biological processes, not a screening test. Its findings explain why the mere detection of a mutation does not constitute a cancer diagnosis and can easily be misunderstood without considering the context of the tissue, the disease, and the examination. [4]
Furthermore, controlling a cell involves more than just the sequence of letters in DNA. Epigenetic marks influence which genes are expressed without altering that sequence. Such mechanisms are part of normal development and may be disrupted in cancer. A report on gene variants therefore does not automatically reflect all the processes that determine a tumor’s behavior. [5]
Purchased, inherited, or newly created: three important terms
A genetic variant is, first and foremost, a permanent deviation in the DNA sequence; the term alone does not indicate anything about its impact on health. Somatic variants arise in body cells during a person’s lifetime and are not necessarily present throughout the entire body. A mutation that occurs exclusively in tumor cells is not passed on to children via egg or sperm cells. [2]
A germline mutation, on the other hand, can be passed on through an egg or sperm cell and subsequently be present in a large number of the child’s cells. Sometimes a variant arises de novo, meaning it was not detectable in the parents. In addition, there are mosaics in which different cell populations carry different variants. Therefore, „No one in our family has had cancer“ is not a reliable answer to every genetic question. [2]
When is it worth taking a closer look at your family history?
Signs of a genetic predisposition may include unusually early onset of the disease, multiple distinct tumors in a single person, or specific clusters of cases among close relatives. Even individual rare types of tumors may warrant genetic counseling. It is important to consider both sides of the family, the age at diagnosis, and the specific type of cancer as accurately as possible. Small families, unknown medical findings, or relatives who died at a young age can mask a hereditary pattern. [8]
For your appointment, you can prepare a simple overview: Who was affected, how are you related to them, what was the diagnosis, and approximately when was it made? Be sure to explicitly note any uncertainties. An unspecified „abdominal cancer“ should not be retroactively identified as a specific type of cancer on your list. Ask family members about any existing medical findings, but do not use their answers to make your own risk assessment.
If possible, genetic testing often begins with a person who is already affected by the disease. The results of this testing can make the examination of healthy relatives more meaningful. If no affected person is available, testing may still be considered; however, a normal result may then have less value in ruling out the condition. Which person is tested first is therefore a substantive decision and not merely an organizational matter. [8]
Tumor tests and genetic predisposition tests answer different questions
During a molecular tumor analysis, the treatment team looks for changes that contribute to the development of the tumor or that may be significant for its treatment. In this process, a distinction is made, among other things, between driving mutations and those that are more likely to be incidental. Even a biologically significant finding does not necessarily mean that a targeted therapy is available. Some results are more indicative of prognosis or potential resistance to a drug. [3]
A test for a hereditary predisposition, on the other hand, determines whether a relevant mutation is also present outside the tumor. Depending on the test, tumor tissue and a suitable control sample are evaluated together. A suspicious tumor finding may prompt additional germline testing; on its own, it is not yet proof that children or siblings carry the same mutation. During your consultation to discuss the results, ask which specific question was actually investigated. [3]
Create a small four-column summary for your records: material examined, research question, result, and agreed-upon course of action. Ask for clarification of any unclear abbreviations during the conversation. For example, ask for a clear explanation of whether a medication is being tested, another sample is needed, or a consultation with the family is recommended. This way, you can avoid a single technical term overshadowing all your decisions.
What an abnormal, normal, or inconclusive result means
If a disease-causing variant is found, the consequences depend on the gene involved and the specific situation. Possible options include tailored early detection, certain preventive measures, or targeted screening of family members. The result does not mean that every person with this predisposition will inevitably develop the disease. A meaningful test result therefore includes a clear recommendation for the next steps. [9]
A negative result initially means that the changes being tested for were not detected. It does not rule out every possible genetic cause: A test does not cover all conceivable genes and variants, and not every medically relevant change is already known. How reassuring the result is also depends on whether a known familial variant was specifically ruled out. The statement „The genetic test was normal“ therefore needs to be clarified by specifying exactly what was tested. [10]
A variant of uncertain significance, often referred to as VUS, is neither definitive evidence of risk nor a clear all-clear. Its implications for health remain unclear. Decisions regarding preventive care should not be based solely on this variant, but rather on factors such as your personal and family medical history. A reassessment at a later date may be advisable; agree on who should be notified if necessary and how you will stay in touch. [9]
A consultation should take place before a genetic test
Genetic testing can be helpful, but it also raises questions about unexpected findings, unclear results, and family members. Professional guidelines therefore emphasize the importance of an informed, voluntary decision. You can decline testing or postpone it for the time being. A larger gene panel is not necessarily better simply because of its size; what matters is whether the genes being tested are relevant to the clinical question and whether the results can be put to meaningful medical use. [11]
Clarify in advance what kind of result would actually change your treatment or preventive care plan, and how incidental findings are handled. Also ask who will conduct the follow-up consultation after you receive your results. A lab report without a clear interpretation leaves important questions unanswered, especially when it comes to unclear variants. A documented family history may also require further counseling, even if no explanatory findings were identified. [11]
In Austria, medical genetics counseling centers offer support before, during, and after genetic testing. Depending on the specific situation, psychological support may also be provided. A referral accompanied by existing pathology reports and known family test results helps ensure that the questions asked are targeted. The Austrian health portal lists the relevant resources. [12]
What Can Influence Prevention—and What Cannot
Classifying an agent as carcinogenic primarily reflects the scientific certainty that it can cause cancer. It does not automatically quantify your personal risk. Factors such as the type, intensity, and duration of exposure are important in determining that risk. Two agents in the same IARC category are therefore by no means equally dangerous. This distinction helps put alarming headlines about individual substances into perspective. When dealing with a specific exposure, it is therefore more helpful to ask: What am I actually coming into contact with, how am I exposed to it, and for how long? A hazard category alone does not answer these questions. Even a long list of supposedly problematic everyday substances is no substitute for an assessment of actual exposure and the available options for reducing it. [6]
Some known cancer risks can be influenced, for example, by managing exposure to tobacco, UV radiation, or certain occupational hazards. Age and family history, on the other hand, cannot be changed. Furthermore, an observed correlation does not necessarily prove a causal relationship: other factors or chance may play a role. Effective prevention reduces risks, but it offers no guarantee and is not a retrospective standard by which those who develop the disease must justify their life choices. [7]
A logical next step
For your next consultation, three questions will suffice for now: Does the finding apply only to my tumor, or possibly to my other cells as well? Is there a valid reason for genetic counseling? What specific decision would further testing change? Write down the answers separately. This way, the vague term „genetic mutation“ becomes information that is understandable even to family members—information that you and your loved ones can work with.
A gene name in a device program is not a genetic test result
A tumor test can look for characteristics that help guide treatment decisions. A germline test examines a different issue: a predisposition that may also exist outside the tumor. The implications for family members become clear only after the diagnosis has been professionally evaluated.[3]
A program that uses a gene or disease name cannot make this distinction. Similarly, a change in a device’s reading does not prove that a variant has disappeared or that a hereditary risk has been eliminated. This would require appropriate molecular testing and separate evidence of medical benefit. In cases of unclear variants, personal and family history remains important; decisions should not be based solely on the “VUS” label.[9]
In the article Scientific Studies on Frequency Therapy I'll explain how such claims about effectiveness are evaluated. What is a biopsy? adds to the question about the material being tested. A brief overview is helpful for the discussion: sample, research question, result, and agreed-upon course of action. This ensures that a genetic finding is linked to a clear decision and does not become a blanket statement about the entire family.
Sources and Further Information
- National Cancer Institute: The Genetics of Cancer. Retrieved October 28, 2026.
- MedlinePlus Genetics: What is a gene variant, and how do variants occur?. Retrieved October 28, 2026.
- NHS Genomics Education: Whole-genome sequencing—information for clinicians. Retrieved October 28, 2026.
- Original study: Somatic mutant clones colonize the human esophagus with age, *Science* 2018. Retrieved October 28, 2026.
- National Human Genome Research Institute: Epigenomics Fact Sheet. Retrieved October 28, 2026.
- IARC: Monographs Program – Frequently Asked Questions About the Classification of Carcinogenic Agents. Retrieved October 28, 2026.
- National Cancer Institute: Risk Factors for Cancer. Retrieved October 28, 2026.
- National Cancer Institute: Cancer Genetics Risk Assessment and Counseling, PDQ. Retrieved October 28, 2026.
- Memorial Sloan Kettering Cancer Center: Frequently Asked Questions About Genetic Test Results. Retrieved October 28, 2026.
- MedlinePlus Genetics: How can genetic test results be interpreted?. Retrieved October 28, 2026.
- eviQ: Guide for Health Professionals Ordering Genetic Testing for Cancer Predisposition, Version 3. Retrieved October 28, 2026.
- Gesundheit.gv.at: Genetic Counseling and Genetic Testing – Counseling Centers. Retrieved October 28, 2026.
Topic Overview: Understanding Tumors.
Comments are closed, but trackbacks and pingbacks are open.